Abstract
ABSTRACT: Children with glycogen storage disease (GSD) type 1b are susceptible to recurrent bacterial infections and have chronic neutropenia accompanied by phagocytic cell dysfunction including decreased superoxide anion (O2−) generation, calcium (Ca2+) mobilization, and chemotactic activity. Granulocyte colony-stimulating factor (G-CSF), a cytokine that corrects neutropenia in other diseases, in vitro enhances f-Met-Leu-Phe-triggered neutrophil O2− generation. Short-term pretreatment (15 min) of GSD 1b neutrophils with G-CSF increased the rate of O2− production (p < 0.01); however, this rate was still significantly below the rate of O2− production in control neutrophils. Recombinant human G-CSF (5 μg/kg/d) was administered s.c. to a GSD 1b patient. Before treatment, absolute neutrophil counts were < 500/mm3. Two d after G-CSF administration, the absolute neutrophil counts increased to 1333 and remained in the normal range during a 12-mo follow-up period. In vivo, G-CSF therapy increased f-Met-Leu-Phe-stimulated O2− production to 52% of control after 1 mo, and by mo 4, O2− production reached control levels. Our previous studies (J Clin Invest 56:196–202, 1990) demonstrated that decreased O2− production in neutrophils was associated with impaired Ca2+ mobilization. In vivo administration of G-CSF increased f-Met-Leu-Phe-triggered Ca2+ mobilization by neutrophils to 43% of control by mo 1 of G-CSF therapy and to 93% of control by mo 4, thus paralleling the improvements in O2− generation. In contrast, G-CSF therapy had no effect on the defective neutrophil chemotaxis. In summary, G-CSF therapy produced a rapid increase in circulating neutrophils and a gradual correction of O2− production. Long-term exposure to G-CSF may be required for correction of both neutropenia and O2− production in GSD 1b patients.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mccawley, L., Korchak, H., Douglas, S. et al. In Vitro and In Vivo Effects of Granulocyte Colony-Stimulating Factor on Neutrophils in Glycogen Storage Disease Type IB: Granulocyte Colony-Stimulating Factor Therapy Corrects the Neutropenia and the Defects in Respiratory Burst Activity and Ca2+ Mobilization. Pediatr Res 35, 84–90 (1994). https://doi.org/10.1203/00006450-199401000-00017
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199401000-00017
This article is cited by
-
Survival, but not maturation, is affected in neutrophil progenitors from GSD‐1b patients
Journal of Inherited Metabolic Disease (2012)
-
Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death
European Journal of Pediatrics (2002)
-
The Mononuclear Phagocyte
Clinical Immunotherapeutics (1995)
-
Glomerular and tubular function in glycogen storage disease
Pediatric Nephrology (1995)